Icotinib Hydrochloride - CAS 1204313-51-8
Catalog number: B0084-457542
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C22H22ClN3O4
Molecular Weight:
427.885
COA:
Inquire
Targets:
EGFR
Description:
Icotinib Hydrochloride is a quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), which is upregulated in a variety of cancer cell types. Icotinib supresses the cancer cell proliferation via EGFR tyrosine kinase inhibition.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-457542 300 mg $299 In stock
Bulk Inquiry
Purity:
>98%
Related CAS:
610798-31-7 (free base)
Synonyms:
Icotinib HCl; BPI-2009; BPI 2009; BPI2009
MSDS:
Inquire
InChIKey:
PNNGXMJMUUJHAV-UHFFFAOYSA-N
InChI:
InChI=1S/C22H21N3O4.ClH/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20;/h1,3-5,12-15H,6-11H2,(H,23,24,25);1H
Canonical SMILES:
C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4.Cl
1.Phase I study of icotinib, an EGFR tyrosine kinase inhibitor combined with IMRT in nasopharyngeal carcinoma.
Hu W1, Wang W2, Yang P3, Zhou C2, Yang W2, Wu B4, Lu H5, Yang H2. Int J Clin Exp Med. 2015 Sep 15;8(9):15675-83. eCollection 2015.
BACKGROUND: Epidermal growth factor receptor (EGFR) is a new target for nasopharyngeal carcinoma (NPC) therapy. This prospective phase I study sought to determine the safety and recommended phase II dose of icotinib, a novel highly selective oral EGFR tyrosine kinase inhibitor, in combination with intensity-modulated radiotherapy (IMRT) in patients with NPC.
2.Personalized biomarkers to monitor disease progression in advanced non-small-cell lung cancer patients treated with icotinib.
Song G1, Liu Y1, Wang Y1, Ren G2, Guo S1, Ren J1, Zhang L2, Li Z3. Clin Chim Acta. 2015 Feb 2;440:44-8. doi: 10.1016/j.cca.2014.11.010. Epub 2014 Nov 15.
BACKGROUND: Disease-specific humoral immune response-related protein complexes in blood are associated with disease progression.
3.Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells.
Ma H1, Bi J1, Liu T1, Ke Y1, Zhang S1, Zhang T1. Oncol Rep. 2015 Mar;33(3):1161-70. doi: 10.3892/or.2014.3699. Epub 2014 Dec 30.
The aim of the present study was to explore the efficacy and mechanism of the radiosensitisation of icotinib hydrochloride (IH), a novel oral epidermal growth factor receptor-tyrosine kinase activity inhibitor, by evaluating the changes in tumour cell double-strand breaks (DSBs) repair, cell cycle and apoptosis following a combination of IH and radiotherapy (RT) in human colorectal adenocarcinoma cell lines. The HT29 and HCT116 human CRC cell lines were treated with IH and/or radiation. Effects on cell viability and cell cycle progression were measured by MTT, a clonogenic survival assay, and flow cytometry. Immunofluorescent staining and western blot analysis were applied to detect the expression of γ-H2AX and 53BP1 in the different treatment groups. Finally, the in vivo effect on the growth of CRC xenografts was assessed in athymic nude mice. IH inhibited the proliferation and enhanced the radiosensitivity in HT29 and HCT116 CRC cells lines.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related EGFR Products


CAS 148741-30-4 AG-879

AG-879
(CAS: 148741-30-4)

AG-879, a tyrphostin compound, is a dual EGFR/HER2 inhibitor that was administered together with androgen withdrawal therapy. It inhibits nerve growth factor (N...

CAS 1035638-91-5 PF 6274484

PF 6274484
(CAS: 1035638-91-5)

PF 6274484 is a high affinity and potent covalent EGFR kinase inhibitor (Ki = 0.14 nM). It inhibits the autophosphorylation of wild-type EGFR in A549 cells and ...

CAS 989-51-5 EGCG

EGCG
(CAS: 989-51-5)

EGCG, also called Epigallocatechin gallate, under the IUPAC name [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxy...

CAS 451492-95-8 AV-412

AV-412
(CAS: 451492-95-8)

AV-412 is a second-generation, orally bioavailable dual kinase inhibitor with potential antineoplastic activity. EGFR/HER2 inhibitor AV-412 binds to and inhibit...

CAS 879127-07-8 EGFR Inhibitor

EGFR Inhibitor
(CAS: 879127-07-8)

A cell-permeable and highly selective EGFR tyrosine kinase inhibitor with IC50 value in the nanomolar range. Inhibition of EGFR induces apoptosis of tumor cells...

CAS 125697-92-9 Lavendustin A

Lavendustin A
(CAS: 125697-92-9)

Lavendustin A is an epidermal growth factor receptor inhibitor tyrosine kinase with IC50 value of 11 nM.

CAS 133550-32-0 Tyrphostin B44, (-) enantiomer

Tyrphostin B44, (-) enantiomer
(CAS: 133550-32-0)

Tyrphostin B44, (-) enantiomer is a potent inhibitor of epidermal growth factor receptor (EGFR) kinase (IC50 = 0.4 μM). More active than the (+) enantiomer.

CAS 383432-38-0 CP-724714

CP-724714
(CAS: 383432-38-0)

CP-724714 is An orally bioavailable quinazoline with potential antineoplastic activity. CP-724,714 selectively binds to the intracellular domain of HER2, revers...

Chemical Structure

CAS 1204313-51-8 Icotinib Hydrochloride

Quick Inquiry

Verification code

Featured Items